About Omega Research Debary, LLC
Clinical Trials at Omega Research Debary, LLC
During the past decade, Omega Research Debary, LLC conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Omega Research Debary, LLC" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "Biogen" with 1 trials
sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Emergo Therapeutics, Inc." with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Omega Research Debary, LLC"
#1 collaborator was "Galapagos NV" with 2 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Omega Research Debary, LLC
According to Clinical.Site data, the most researched conditions in "Omega Research Debary, LLC" are
"Psoriatic Arthritis" (2 trials), "COVID-19" (1 trials), "Chronic Cutaneous Lupus Erythematosus" (1 trials), "Influenza" (1 trials) and "Influenza -Like Illness" (1 trials). Many other conditions were trialed in "Omega Research Debary, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Omega Research Debary, LLC
Most popular intervention types in "Omega Research Debary, LLC" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Filgotinib" (2 trials), "Placebo" (2 trials), "Placebo to match filgotinib" (2 trials), "Adalimumab" (1 trials) and "BIIB059 (litifilimab)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Omega Research Debary, LLC
The vast majority of trials in "Omega Research Debary, LLC" are
5 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Omega Research Debary, LLC
Currently, there are NaN active trials in "Omega Research Debary, LLC".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Omega Research Debary, LLC,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Omega Research Debary, LLC, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".